Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.

Abstract excerpt

Understanding the dose-exposure-response relationship across the pediatric age spectrum from preterm and term newborns to infants, children, adolescents, and adults is a major challenge for clinicians, pharmaceutical companies, and regulatory agencies. Over the past 3 decades, clinical investigations of many drugs commonly used in pediatric therapeutics have provided valuable insights into age-associated...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child Development
• Share to Cough
• Share to Drug Design